[Funtional phase IV?].
Heinzl
Susanne
S
D017327:Clinical Trials, Phase IV as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000453:epidemiology; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib